Accordingly, the 2021 KDIGO guideline states that a “kidney biopsy is not required to confirm the diagnosis of membranous nephropathy (MN) in patients with nephrotic syndrome and a positive anti-PLA2R antibody test” [10]. The gene discussed is PLA2R1; the disease is membranous glomerulonephritis.